Considering Loxapine Instead of Clozapine: A Case Series and Literature Review.

antipsychotics atypical clozapine loxapine noncompliance sialorrhea

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
26 Jan 2021
Historique:
entrez: 3 3 2021
pubmed: 4 3 2021
medline: 4 3 2021
Statut: epublish

Résumé

This case series highlights the importance of loxapine in psychiatric disorders when clozapine is unable to control agitation and psychotic symptoms due to medication noncompliance, intolerable side effects, or inadequate clinical outcomes. Loxapine is classified as a first-generation typical antipsychotic but displays atypical antipsychotic-like characteristics with structural similarity to clozapine. However, since the inception of second-generation antipsychotic medications, the role of loxapine in modern psychiatric practice has become limited. Loxapine has been underutilized due to concerns of side effects and lack of in-depth research about its safety, tolerability, and efficacy. This report revisits loxapine's clinical utility through two well-studied long-term inpatient cases, where it played a crucial role in controlling psychotic symptoms and achieving better medication compliance by eliminating significant barriers, including monitoring regular differential complete blood counts. We aim to add to the current evidence and literature about the advantage of using loxapine for specific clinical scenarios in psychiatric practice.

Identifiants

pubmed: 33654602
doi: 10.7759/cureus.12919
pmc: PMC7906363
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e12919

Informations de copyright

Copyright © 2021, Shrestha et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Ann Gen Psychiatry. 2015 Apr 01;14:15
pubmed: 25859275
J Anal Toxicol. 2000 Oct;24(7):638-41
pubmed: 11043672
J Clin Psychiatry. 1999;60 Suppl 10:42-6
pubmed: 10340686
Drugs. 2013 Nov;73(16):1783-92
pubmed: 24151084
Hum Psychopharmacol. 2016 Jul;31(4):268-85
pubmed: 27151529
Int J Clin Pract. 2011 Mar;65(3):330-40
pubmed: 21199198

Auteurs

Shristi Shrestha (S)

Psychiatry, Texas Tech University Health Sciences Center, Midland, USA.

Raafae S Agha (RS)

Psychiatry, Texas Tech University Health Sciences Center, Midland, USA.

Zershana Khan (Z)

Psychiatry, Texas Tech University Health Sciences Center, Midland, USA.

Kaushal Shah (K)

Psychiatry, Griffin Memorial Hospital, Norman, USA.

Shailesh Jain (S)

Psychiatry, Texas Tech University Health Sciences Center, Midland, USA.

Classifications MeSH